EUVIMEDEUVIMED entdecken
Kommentar

Quality of life: a crucial aspect for the patients, a neglected goal in the treatment of anemia in patients with CKD

Francesco Locatelli, Lucia Del Vecchio

Kidney International · 2023

DOI: 10.1016/j.kint.2023.03.026 ↗

Kurz gefasst

Kommentar in der Zeitschrift Kidney International, 2023. Verfasst von Francesco Locatelli und 1 weiteren Autor:innen. Beteiligte Einrichtung: Past Director, Department of Nephrology and Dialysis, Alessandro Manzoni Hospital, Lecco, Italy. Electronic address: francesco.locatelli2210@outlook.…. Hauptthemen laut MEDLINE: Anemia, Renal Insufficiency, Chronic, Hematinics. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 9 Literaturangaben. Gefördert von: Astellas Pharma US, Vifor Pharma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of any treatment should be to add life to years and not simply years to life. Surprisingly, the label of erythropoiesis-stimulating agents for anemia treatment in chronic kidney disease does not include the indication for improving quality of life. Merit of the placebo-controlled Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ) trial was to address this issue by analyzing the effect of anemia treatment with daprodustat aimed at the hemoglobin target range of 11-12 g/dl; the trial demonstrates that partial anemia correction improved quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnemiaRenal Insufficiency, ChronicHematinicsHumansQuality of LifeGoalsHemoglobins

Substanzen

HemoglobinsHematinics

Autor:innen und Institutionen

  • Past Director, Department of Nephrology and Dialysis, Alessandro Manzoni Hospital, Lecco, Italy. Electronic address: francesco.locatelli2210@outlook.it.
  • Department of Nephrology and Dialysis, Sant' Anna Hospital, ASST Lariana, Como, Italy.

Förderung

  • Astellas Pharma US
  • Vifor Pharma

Zitieren

APA

Locatelli, F., & Del Vecchio, L. (2023). Quality of life: a crucial aspect for the patients, a neglected goal in the treatment of anemia in patients with CKD. Kidney International. https://doi.org/10.1016/j.kint.2023.03.026

Vancouver

Locatelli F, Del Vecchio L. Quality of life: a crucial aspect for the patients, a neglected goal in the treatment of anemia in patients with CKD. Kidney International. 2023. doi:10.1016/j.kint.2023.03.026

BibTeX
@article{Locatelli2023,
  author = {Locatelli, Francesco and Del Vecchio, Lucia},
  title = {Quality of life: a crucial aspect for the patients, a neglected goal in the treatment of anemia in patients with CKD},
  journal = {Kidney International},
  year = {2023},
  doi = {10.1016/j.kint.2023.03.026}
}
Kostenlos starten →